ITC Seeks Input on Battery Tech Trade Complaint Issues

2026-18586, Citric Acid and Certain Citrate Salts From Canada and India; Scheduling of the Final Phase of Countervailing Duty and Antidumping Duty Investigations

The Commission hereby gives notice of the scheduling of the final phase of antidumping and countervailing duty investigation Nos. 701-TA-783-784 and 731-TA-1771-1772 (Final) pursuant to the Tariff Act of 1930 to determine whether an industry in the United States is materially injured or threatened with material injury, or the establishment of an industry in the United States is materially retarded, by reason of imports of citric acid and certain citrate salts, provided for in subheadings 2918.14.00, 2918.15.10, 2918.15.50, and 3824.99.93 of the Harmonized Tariff Schedule of the United States, from China that have been preliminarily determined by the Department of Commerce ("Commerce") to be subsidized by the government of China and sold at less-than-fair-value, and by reason of imports of citric acid and certain citrate salts from Canada that have been preliminarily determined by Commerce to be subsidized by the government of Canada but preliminarily determined by Commerce not to be, or not likely to be, sold at less-than-fair-value.

2026-18367, Hardwood and Decorative Plywood From China, Indonesia, and Vietnam; Determinations

The U.S. has found that imports of hardwood and decorative plywood from China, Indonesia, and Vietnam are hurting American businesses because they're being sold unfairly cheap or getting government help. As a result, the government will keep rules in place to protect U.S. plywood makers, which could mean extra costs for importers starting soon. This helps American companies stay strong and fair in the market.

2026-18379, Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest

The U.S. International Trade Commission got a complaint from trinamiX about some mobile devices and parts, pointing fingers at Apple. They’re asking for rules to stop these products from being sold in the U.S. while the case is reviewed. If you’re interested, you can share your thoughts soon—this could shake up the tech world and affect sales during the next two months.

2026-18302, Certain Glow Fish Tape Systems, Safety Helmet Systems, and Components Thereof; Notice of a Commission Determination To Review in Part a Final Initial Determination Finding a Violation of Section 337; Request for Written Submissions on the Issues Under Review, Remedy, Bond, and the Public Interest

Notice is hereby given that the U.S. International Trade Commission ("the Commission") has determined to review in part a final initial determination ("FID") issued by the presiding chief administrative law judge's ("CALJ") in the above-captioned investigation finding a violation of section 337 of the Tariff Act of 1930, and to solicit briefing on the issues under review as well as remedy, bonding, and the public interest.

2026-18195, L-Lysine From China

2026-18101, Certain Photodynamic Therapy Systems, Components Thereof, and Pharmaceutical Products Used in Combination With the Same; Notice of the Commission's Determination To Lift the Partial Suspension of Enforcement of the Remedial Orders as to U.S. Patent No. 11,697,028

Notice is hereby given that the U.S. International Trade Commission ("Commission") has determined to grant a request submitted by Sun Pharmaceutical Industries, Inc. ("Complainant") of Princeton, New Jersey to lift the partial suspension of enforcement of the limited exclusion order ("LEO") and cease and desist orders ("CDOs") as to U.S. Patent No. 11,697,028 ("the '028 patent").

Previous: 2026-15061, ETF Opportunities Trust and Hedgeye Asset Management, LLC

Next: 2026-15064, Certain Dermatological Treatment Devices and Components Thereof II; Notice of Institution of Investigation

Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on June 22, 2026, under section 337 of the Tariff Act of 1930, as amended, on behalf of Serendia, LLC of Los Angeles, California. Supplements were filed on July 6 and 13, 2026. The complaint, as supplemented, alleges violations of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain dermatological treatment devices and components thereof by reason of the infringement of certain claims of U.S. Patent No. 9,320,536 ("the '536 patent"); U.S. Patent No. 9,775,774 ("the '774 patent"); U.S. Patent No. 10,869,812 ("the '812 patent"); and U.S. Patent No. 12,220,549 ("the '549 patent"). The complaint, as supplemented, further alleges that an industry in the United States exists as required by the applicable Federal Statute. The complainant requests that the Commission institute an investigation and, after the investigation, issue a limited exclusion order and cease and desist orders.